Evidence map›Paper›PMID 34033300›Full record

ArticleArchives of endocrinology and metabolism2021

Central nervous system imaging in girls with central precocious puberty: when is necessary?

Dogus Vuralli, E Nazli Gonc, Ayfer Alikasifoglu, Nurgun Kandemir, Z Alev Ozon

Open access · diamondAbstract read
In one paragraph

Article in Archives of endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dogus VuralliHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey, dvuralli@hotmail.com.
E Nazli GoncHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey.
Ayfer AlikasifogluHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey.
Nurgun KandemirHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey.
Z Alev OzonHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey.
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe determinants of an increased risk of an organic pathology underlying central precocious puberty (CPP) in girls remain contentious. The present study aimed to determine the clinical and hormonal findings that can be used to differentiate organic and idiopathic CPP in girls as a screening method so that only those considered likely to have organic CPP undergo cranial magnetic resonance imaging (MRI).

methodsThe medical records of 286 girls that received GnRH agonist (GnRHa) therapy for CPP were retrospectively evaluated. Chronological and bone age, height, pubertal stage, and basal/stimulated gonadotropin and estradiol (E

resultsOrganic CPP was noted in 6.3% of the participants. Puberty started before age 6 years in 88.9% of the girls with organic CPP. Mean E

conclusionPubertal symptoms and signs generally begin before age 6 years and hormone levels are much higher than expected for pubertal stage in girls with organic CPP. Based on the present findings, cranial MRI is recommended for girls aged < 6 years, as the risk of diagnosing an organic pathology is highest in this age group. Hormone levels higher than expected for pubertal stage might be another indication for cranial MRI, regardless of patient age. Cranial MRI should be performed in girls with early-stage puberty, and an E

Indexed as

Puberty, PrecociousCentral Nervous SystemChildFemaleFollicle Stimulating HormoneGonadotropin-Releasing HormoneHumansLuteinizing HormoneRetrospective StudiesFollicle Stimulating HormoneGonadotropin-Releasing HormoneLuteinizing HormoneCentral nervous systemcentral precocious pubertyidiopathic sexual precocitymagnetic resonance imaging

Identifiers

PMID34033300
PMCPMC10118962
OpenAlexW3035946545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.